Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes

In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect auto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreas 2017-04, Vol.46 (4), p.455-466
1. Verfasser: Mullen, Yoko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 466
container_issue 4
container_start_page 455
container_title Pancreas
container_volume 46
creator Mullen, Yoko
description In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect autoimmune islet damage, and facilitated development of early detection, prevention, and treatment of type 1 diabetes. The genetic characterization, monoclonal antibodies, and congenic strains have made NOD mice especially useful.Although the establishment of the inbred NOD mouse strain was documented by Makino et al (Jikken Dobutsu. 1980;29:1-13), this review will focus on the not-as-well-known history leading to the discovery of a glycosuric female mouse by Yoshihiro Tochino. This discovery was spearheaded by years of effort by Japanese scientists from different disciplines and dedicated animal care personnel and by the support of the Shionogi Pharmaceutical Company, Osaka, Japan. The history is based on the early literature, mostly written in Japanese, and personal communications especially with Dr Tochino, who was involved in diabetes animal model development and who contributed to the release of NOD mice to the international scientific community. This article also reviews the scientific contributions made by the Bio-Breeding rat to autoimmune diabetes.
doi_str_mv 10.1097/MPA.0000000000000828
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5359790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1877527472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-c883240a9c20feb5f207d0f42211eb6ba3321bc3bdb6c036890a759c89365c223</originalsourceid><addsrcrecordid>eNpdUclOwzAQtRAIyvIHCPnIJeAliZ0LUtWySRQ4lLNlOxMwSu1ip0j8Pa4oCJjLzGjevFkeQseUnFHSiPPZ4_iM_DbJ5BYa0YrXRZnjbTQiUlYFp0Lsof2UXgmhglfNLtpjkjWU1nSE_BTeoQ_LBfgBhw4PL4Dvgw8GEuCp0wYGZ_EsrHKqfYsnwQ_RmdXggl_jx94tdJ8BLfQJdyHiJ99CTEMGO_-M5x9LwHTDBOkQ7XS6T3C08Qfo6epyPrkp7h6ubyfju8KWohwKKyVnJdGNZaQDU3WMiJZ0JWOUgqmN5pxRY7lpTW0Jr2VDtKgaKxteV5YxfoAuvniXK7OA1ubrou7VMuZt44cK2qm_Fe9e1HN4V1V-kGhIJjjdEMTwtoI0qIVLFvpee8jPUFQKUTFRivWs8gtqY0gpQvczhhK1lkplqdR_qXLbye8Vf5q-teGf_8aQKw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1877527472</pqid></control><display><type>article</type><title>Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Mullen, Yoko</creator><creatorcontrib>Mullen, Yoko</creatorcontrib><description>In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect autoimmune islet damage, and facilitated development of early detection, prevention, and treatment of type 1 diabetes. The genetic characterization, monoclonal antibodies, and congenic strains have made NOD mice especially useful.Although the establishment of the inbred NOD mouse strain was documented by Makino et al (Jikken Dobutsu. 1980;29:1-13), this review will focus on the not-as-well-known history leading to the discovery of a glycosuric female mouse by Yoshihiro Tochino. This discovery was spearheaded by years of effort by Japanese scientists from different disciplines and dedicated animal care personnel and by the support of the Shionogi Pharmaceutical Company, Osaka, Japan. The history is based on the early literature, mostly written in Japanese, and personal communications especially with Dr Tochino, who was involved in diabetes animal model development and who contributed to the release of NOD mice to the international scientific community. This article also reviews the scientific contributions made by the Bio-Breeding rat to autoimmune diabetes.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/MPA.0000000000000828</identifier><identifier>PMID: 28291161</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Animals ; Autoimmunity - genetics ; Diabetes Mellitus, Type 1 - genetics ; Diabetes Mellitus, Type 1 - pathology ; Diabetes Mellitus, Type 1 - therapy ; Disease Models, Animal ; Humans ; Islets of Langerhans - metabolism ; Islets of Langerhans - pathology ; Mice, Inbred NOD ; Rats ; Review</subject><ispartof>Pancreas, 2017-04, Vol.46 (4), p.455-466</ispartof><rights>Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. 2017 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-c883240a9c20feb5f207d0f42211eb6ba3321bc3bdb6c036890a759c89365c223</citedby><cites>FETCH-LOGICAL-c474t-c883240a9c20feb5f207d0f42211eb6ba3321bc3bdb6c036890a759c89365c223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28291161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mullen, Yoko</creatorcontrib><title>Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect autoimmune islet damage, and facilitated development of early detection, prevention, and treatment of type 1 diabetes. The genetic characterization, monoclonal antibodies, and congenic strains have made NOD mice especially useful.Although the establishment of the inbred NOD mouse strain was documented by Makino et al (Jikken Dobutsu. 1980;29:1-13), this review will focus on the not-as-well-known history leading to the discovery of a glycosuric female mouse by Yoshihiro Tochino. This discovery was spearheaded by years of effort by Japanese scientists from different disciplines and dedicated animal care personnel and by the support of the Shionogi Pharmaceutical Company, Osaka, Japan. The history is based on the early literature, mostly written in Japanese, and personal communications especially with Dr Tochino, who was involved in diabetes animal model development and who contributed to the release of NOD mice to the international scientific community. This article also reviews the scientific contributions made by the Bio-Breeding rat to autoimmune diabetes.</description><subject>Animals</subject><subject>Autoimmunity - genetics</subject><subject>Diabetes Mellitus, Type 1 - genetics</subject><subject>Diabetes Mellitus, Type 1 - pathology</subject><subject>Diabetes Mellitus, Type 1 - therapy</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Islets of Langerhans - metabolism</subject><subject>Islets of Langerhans - pathology</subject><subject>Mice, Inbred NOD</subject><subject>Rats</subject><subject>Review</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUclOwzAQtRAIyvIHCPnIJeAliZ0LUtWySRQ4lLNlOxMwSu1ip0j8Pa4oCJjLzGjevFkeQseUnFHSiPPZ4_iM_DbJ5BYa0YrXRZnjbTQiUlYFp0Lsof2UXgmhglfNLtpjkjWU1nSE_BTeoQ_LBfgBhw4PL4Dvgw8GEuCp0wYGZ_EsrHKqfYsnwQ_RmdXggl_jx94tdJ8BLfQJdyHiJ99CTEMGO_-M5x9LwHTDBOkQ7XS6T3C08Qfo6epyPrkp7h6ubyfju8KWohwKKyVnJdGNZaQDU3WMiJZ0JWOUgqmN5pxRY7lpTW0Jr2VDtKgaKxteV5YxfoAuvniXK7OA1ubrou7VMuZt44cK2qm_Fe9e1HN4V1V-kGhIJjjdEMTwtoI0qIVLFvpee8jPUFQKUTFRivWs8gtqY0gpQvczhhK1lkplqdR_qXLbye8Vf5q-teGf_8aQKw</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Mullen, Yoko</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170401</creationdate><title>Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes</title><author>Mullen, Yoko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-c883240a9c20feb5f207d0f42211eb6ba3321bc3bdb6c036890a759c89365c223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Autoimmunity - genetics</topic><topic>Diabetes Mellitus, Type 1 - genetics</topic><topic>Diabetes Mellitus, Type 1 - pathology</topic><topic>Diabetes Mellitus, Type 1 - therapy</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Islets of Langerhans - metabolism</topic><topic>Islets of Langerhans - pathology</topic><topic>Mice, Inbred NOD</topic><topic>Rats</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mullen, Yoko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mullen, Yoko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>46</volume><issue>4</issue><spage>455</spage><epage>466</epage><pages>455-466</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><abstract>In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect autoimmune islet damage, and facilitated development of early detection, prevention, and treatment of type 1 diabetes. The genetic characterization, monoclonal antibodies, and congenic strains have made NOD mice especially useful.Although the establishment of the inbred NOD mouse strain was documented by Makino et al (Jikken Dobutsu. 1980;29:1-13), this review will focus on the not-as-well-known history leading to the discovery of a glycosuric female mouse by Yoshihiro Tochino. This discovery was spearheaded by years of effort by Japanese scientists from different disciplines and dedicated animal care personnel and by the support of the Shionogi Pharmaceutical Company, Osaka, Japan. The history is based on the early literature, mostly written in Japanese, and personal communications especially with Dr Tochino, who was involved in diabetes animal model development and who contributed to the release of NOD mice to the international scientific community. This article also reviews the scientific contributions made by the Bio-Breeding rat to autoimmune diabetes.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>28291161</pmid><doi>10.1097/MPA.0000000000000828</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-3177
ispartof Pancreas, 2017-04, Vol.46 (4), p.455-466
issn 0885-3177
1536-4828
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5359790
source MEDLINE; Journals@Ovid Complete
subjects Animals
Autoimmunity - genetics
Diabetes Mellitus, Type 1 - genetics
Diabetes Mellitus, Type 1 - pathology
Diabetes Mellitus, Type 1 - therapy
Disease Models, Animal
Humans
Islets of Langerhans - metabolism
Islets of Langerhans - pathology
Mice, Inbred NOD
Rats
Review
title Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T14%3A11%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20the%20Nonobese%20Diabetic%20Mouse%20and%20Contribution%20of%20Animal%20Models%20for%20Understanding%20Type%201%20Diabetes&rft.jtitle=Pancreas&rft.au=Mullen,%20Yoko&rft.date=2017-04-01&rft.volume=46&rft.issue=4&rft.spage=455&rft.epage=466&rft.pages=455-466&rft.issn=0885-3177&rft.eissn=1536-4828&rft_id=info:doi/10.1097/MPA.0000000000000828&rft_dat=%3Cproquest_pubme%3E1877527472%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1877527472&rft_id=info:pmid/28291161&rfr_iscdi=true